transplantation tourism n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Transplantation Tourism PowerPoint Presentation
Download Presentation
Transplantation Tourism

Loading in 2 Seconds...

play fullscreen
1 / 66

Transplantation Tourism - PowerPoint PPT Presentation


  • 209 Views
  • Uploaded on

Transplantation Tourism. Mohammed Alsaghier, MBBS MultiOrgan Transplant Surgeon King Fahed Specialist Hospital Damamm , Saudi Arabia. Outline of Presentation. Background Challenges for transplant on Saudi Arabia Transplant Tourism China Conclusions. Issues with Transplant Tourism.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

Transplantation Tourism


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
    Presentation Transcript
    1. Transplantation Tourism Mohammed Alsaghier, MBBS MultiOrgan Transplant Surgeon King Fahed Specialist Hospital Damamm , Saudi Arabia

    2. Outline of Presentation Background Challenges for transplant on Saudi Arabia Transplant Tourism China Conclusions

    3. Issues with Transplant Tourism Clinical / Medical Financial Ethical Legal

    4. Introduction

    5. No of Dialysis units on Saudi Arabia1971-2007

    6. 1993-2007 No of Patients

    7. 2007Age distribution by

    8. The future patients1995-2015م

    9. No of new patient per Million

    10. Transplant global history Research for transplant: one hundred years ago Alexis Carrel (Nobel Prize 1912) WW II, kidney transplants between identical twins immunosuppression living donors First heart transplant (1967) “Definition” of brain death Growing no organs from deceaseddonors (DD) Supply never meets the need (waiting lists) Transplantation becomes global practice 1980s:organ traffickingand Tourism.

    11. DECEASED DONATION

    12. Deceased donors Donor has been declared dead by two physicians independent of the transplant team Usually occurs only in cases of neurologically determined death Live donors to donate one or part of an organ to someone on a transplant waiting list. DONATION

    13. Yearly Number of kidney transplant per million population per year - USA - 52 Predominantly Deceased Donors Europe - 27 Predominantly Deceased Donors Asia - 3 Predominantly Living Donors WORLD STATUS OF RENAL TRANSPLANTS

    14. The deceased donors per million population per year USA - 20.7 Europe - 15.9 Asia - 1.1 South America - 2.6 DECEASED DONOR RATES

    15. 1986-2007

    16. 1986-2007

    17. The successful Donation from DD1986-2007

    18. DD Reported 2008

    19. Reason for Donation Rejection1986-2007م

    20. Incidence of End Stage Organ failure Community and professional Mind-set to Brain Death and Donation Legal aspect Trained Donor Coordinators COMMON PROBLEMS IN DD TRANSPLANT

    21. Public awarness Reporting of Brain Death Hospitals Donation system . Religion , Society and Organ Donation COMMON PROBLEMS IN DD

    22. System Funding for Donor program Hospitals work to identify & maintain “Brain Dead” donors Community Awareness of “Brain- Death” Concept PROBLEMS WITH DD Transplant For cadaveric donation, ‘ Society acceptance remains a crucial in a transplant program’

    23. Hospitals Donation System Trained transplant Co-coordinators Adequate No. of Intensivists in ICUs Well qualified Surgeons to undertake Retrieval & TX Support Organization to SCOT Transport of organs –between cities HLA Tissue typing and Cross-match

    24. ... و مَنَ اَحياها فَكَاَ نما اَحيَا الناسَ جميعاً ... And he who saves a man’s life shall be considered as one who has saved the life of mankind as a whole

    25. Transplantation Tourism

    26. Issues Living donors Autonomy vs. nonmaleficence Risks to Donor ( “benefit”) Deceased donors Brain death (accuracy; conflict of interests) Consent? Waiting lists Allocation (medical vs. social) “Shortage” Commercialism Autonomy vs. desperate “donors” ) Transplant tourism ( “ deal” including donor, at “bargain” )

    27. Japan - 12,974 Taiwan - 7000 Saudi Arabia - 4248 Korea - 4000 Pakistan - 1650 Hong Kong - 1018 Singapore - 666 Bangladesh - 125 Waiting Time Taiwan – 1.9 yrs Korea – 2.2 yrs Hong Kong – 4.3 yrs Singapore – 5.8 yrs No Waiting list in Iran for Kidney Tx. KIDNEY TX WAITING LIST IN ASIA (2002)

    28. KIDNEY TX WAITING LIST IN THE WORLD (2002)

    29. Five organ trafficking hotpots identified by the WHO CHINA PAKISTAN EGYPT COLOMBIA PHILIPPINES 2007 Sources: Reuters, World Health Organization

    30. Clinical Outcomes for Saudi Patients Receiving Deceased Donor Liver Transplantation in China 2King Faisal Specialist Hospital & Research Center – Saudi Arabia

    31. consequent increase in the number of patients seeking transplant abroad especially in China. Attracting factors in China: easy accessibility. relatively low cost, relatively short waiting time. laxtransplantation indications.

    32. Despite these attractive factors, the main growing concern with this choice is the uncertaintyregarding the outcome ……

    33. Seventy-four adult patients (60 males & 14 females). Mean age: 54.7 years. Nationality: Forty-six Saudi nationals; 28 Egyptians. Average MELD score: 17. In 5 patients (6.8%) MELD score > 25. Indications for liver transplantation: hepatitis C related decompensated cirrhosis (n=29). hepatocellular carcinoma (n=24). hepatitis B (n=14). cryptogenic cirrhosis (n=6). primary biliary cirrhosis (n=1). Median period between contacting centre & travel: 4 weeks (2-16w). RESULTS

    34. 41 patients (55%) had been deniedlive transplantation in KSA or in Egypt. Reasons for rejection of transplantation: unsuitable medical condition due to multiple co-morbidities (n=23), age >65 (n=13), advanced hepatocellular carcinoma (n=5). three patients: tumor size > Milan and UCSF criteria; one: invasion of the right branch of the portal vein; one: invasion of the main portal vein.

    35. Reports from China In-China waiting period: 5-20 days (median14 days). Donors’ data: Only the age of the donor (range 20-35 years, median 25 years) & the cause of death (severe brain injury in all cases) were provided. Operative details: missing or incomplete. Early post-operative morbidity: Complications were rarely described in detail. Mortality: Two patients died in China, due to unknown cause.

    36. Follow up care for a median of 13 months (2-60 months). Follow up after return from China

    37. Complications

    38. Biliary complications

    39. Diffuse biliary stricture: 14 (18.9%) Six died. The rest required repeated interventions (ERCP, PTC). Two required surgery and one required retransplantation. Anastomotic stricture: 6 (8.1%) Bileleakage:4 (5.4%) Biliary Complications

    40. Mortality Two patients died in China very early after surgery. Sixteen died during follow up: biliary complications resulting in either sepsis or poor graft function (10 patients). recurrent metastatic HCC (3 patients). poor graft function due to portal vein thrombosis (1 patient). GVHD (1 patient). fibrosingcholestatic hepatitis (1 patient).

    41. Outcome of patients rejected for Tx in KSA • Age above sixty-five: revise • Eight died in the first year post-transplant, • Two had portal vein thrombosis, one had biliary stricture, five required repeated admissions to the hospital during the first year, and three suffered from severe infections. • Rejected due to advanced HCC • Four died in the 1st year post transplant, three of whom suffered from brain or lung metastasis. • One died after two months of severe pneumonia and sepsis.

    42. Comparison of Outcome with patients at KFSH

    43. Patient Survival rate Survival Functions 1.0 0.8 0.6 0.4 0.2 0.0 Country Saudi Arabia China 1.00 - Censored Cum Survival 2.00 - Censored 0 500 1000 1500 2000 Survival ( Days )

    44. Graft Survival rate Survival Functions 1.0 0.8 0.6 0.4 0.2 0.0 Country 1 2 1 - Censored 2 - Censored Cum Survival 0 500 1000 1500 2000 0 500 1000 1500 2000 Survival ( Days )

    45. Incidence of Complications

    46. Medical Care Postoperative interventions. Frequent hospital admissions. Frequent Visits to day medical unit. Frequent Visits to the ER. Frequent Laboratory investigations. Burden on the Hospital resources.

    47. The results in this study may not represent the actual survival data of the Chinese centers. Indeed, the presented data from China are only of the patients who are followed up in our center, and do not include those who may have had early death or complications, those who are followed elsewhere, and all other non-Saudi & non-Egyptian patients not known to us.

    48. Renal Transplant – Favorable Outcomes Sever MS et al 1997 540 Saudi patients transplanted in India 96% graft survival 89% patient survival Similar results to those transplanted in Saudi Arabia Pediatr Nephrol. 2006 Morad et al 2000 515 Malaysian patients transplanted in China or India >90% graft and patient survival Transplant Proc. 2000 Nov

    49. Renal Transplant - Inferior Outcomes Kennedy et al 2005 16 Australian patients 66% graft survival 85% patient survival Sever et al 2001 Turkish patients 84% graft survival patient survival similar to locally transplanted patients